$2.28T
Total marketcap
$110.33B
Total volume
BTC 49.98%     ETH 15.48%
Dominance

Diaceutics PLC 7DC.F Stock

1.19 EUR {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
103.07M EUR
LOW - HIGH [24H]
1.18 - 1.19 EUR
VOLUME [24H]
1K EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR

Diaceutics PLC Price Chart

Diaceutics PLC 7DC.F Financial and Trading Overview

Diaceutics PLC stock price 1.19 EUR
Previous Close 0.98 EUR
Open 0.98 EUR
Bid 0.98 EUR x 0
Ask 1.05 EUR x 0
Day's Range 0.98 - 0.98 EUR
52 Week Range 0.82 - 1.39 EUR
Volume 3K EUR
Avg. Volume 71 EUR
Market Cap 84.88M EUR
Beta (5Y Monthly) 0.324964
PE Ratio (TTM) 98.00001
EPS (TTM) 0 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

7DC.F Valuation Measures

Enterprise Value 64.07M EUR
Trailing P/E 98.00001
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 4.3520813
Price/Book (mrq) 1.9405941
Enterprise Value/Revenue 3.285
Enterprise Value/EBITDA 30.861

Trading Information

Diaceutics PLC Stock Price History

Beta (5Y Monthly) 0.324964
52-Week Change -19.0082%
S&P500 52-Week Change 20.43%
52 Week High 1.39 EUR
52 Week Low 0.82 EUR
50-Day Moving Average 1.06 EUR
200-Day Moving Average 1 EUR

7DC.F Share Statistics

Avg. Volume (3 month) 71 EUR
Avg. Daily Volume (10-Days) 300 EUR
Shares Outstanding 84.47M
Float 46.53M
Short Ratio N/A
% Held by Insiders 46.78%
% Held by Institutions 47.41%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 3.71%
Operating Margin (ttm) 2.94%
Gross Margin 85.83%
EBITDA Margin 10.64%

Management Effectiveness

Return on Assets (ttm) 0.77%
Return on Equity (ttm) 1.74%

Income Statement

Revenue (ttm) 19.5M EUR
Revenue Per Share (ttm) 0.23 EUR
Quarterly Revenue Growth (yoy) 50.10%
Gross Profit (ttm) 16.74M EUR
EBITDA 2.08M EUR
Net Income Avi to Common (ttm) 724K EUR
Diluted EPS (ttm) 0.01
Quarterly Earnings Growth (yoy) 66.40%

Balance Sheet

Total Cash (mrq) 19.84M EUR
Total Cash Per Share (mrq) 0.24 EUR
Total Debt (mrq) 1.33M EUR
Total Debt/Equity (mrq) 3.13 EUR
Current Ratio (mrq) 8.235
Book Value Per Share (mrq) 0.505

Cash Flow Statement

Operating Cash Flow (ttm) 5.1M EUR
Levered Free Cash Flow (ttm) -354625 EUR

Profile of Diaceutics PLC

Country Germany
State N/A
City Belfast
Address Building Two
ZIP BT9 6GW
Phone N/A
Website https://www.diaceutics.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 151

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Q&A For Diaceutics PLC Stock

What is a current 7DC.F stock price?

Diaceutics PLC 7DC.F stock price today per share is 1.19 EUR.

How to purchase Diaceutics PLC stock?

You can buy 7DC.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Diaceutics PLC?

The stock symbol or ticker of Diaceutics PLC is 7DC.F.

Which industry does the Diaceutics PLC company belong to?

The Diaceutics PLC industry is Diagnostics & Research.

How many shares does Diaceutics PLC have in circulation?

The max supply of Diaceutics PLC shares is 86.62M.

What is Diaceutics PLC Price to Earnings Ratio (PE Ratio)?

Diaceutics PLC PE Ratio is now.

What was Diaceutics PLC earnings per share over the trailing 12 months (TTM)?

Diaceutics PLC EPS is 0 EUR over the trailing 12 months.

Which sector does the Diaceutics PLC company belong to?

The Diaceutics PLC sector is Healthcare.